Intra-Aortic Balloon Pumps: Timing, Traces and Trials

Two in the morning, day one after a long CABG. The patient has a balloon pump in, the augmented pressure has dropped, and the urine output has fallen away over the last three hours. The easiest thing in the world at that hour is to re-zero the transducer, decide the trace looks a bit better, and go back to what you were doing. By the end of this episode you'll know exactly why that's the wrong answer. This is the intra-aortic balloon pump, top to bottom, pitched at Final FRCA and a bit past it — it has appeared in past papers three separate ways, as principles, as indications and contraindications, and as complications. But the version worth having is the one where you can look at a trace on the unit and know what's wrong with it. Please note: the weaning approach and anticoagulation discussed are Wythenshawe-specific local practice. Take the principles, and check your own guidelines. We start with helium, and the two reasons to give rather than one — it's low density, so it shuttles down a long narrow catheter fast enough to work inside a fraction of a cardiac cycle, and it's highly soluble in blood, so rupture is far more forgiving than air would be. Then counterpulsation, and the sentence the whole device hangs on: the balloon pump increases myocardial oxygen supply and reduces demand at the same time, which almost nothing else does. Give adrenaline to an ischaemic ventricle and coronary perfusion may improve, but rate, contractility and wall stress have all gone up, so you've bought a little flow at a large metabolic price. Diastolic augmentation raises coronary perfusion pressure, presystolic deflation drops aortic end-diastolic pressure and therefore afterload and wall stress — supply up, demand down. Then the trace, as a learnable set piece. The rule first: put the pump on 1:2, so every other beat is unassisted and you have a control sitting next to your test. Then three comparisons in order — augmented diastolic higher than unassisted systolic, assisted end-diastolic lower than unassisted end-diastolic, and assisted systolic lower than unassisted systolic. That last one catches people every time: a lower assisted systolic pressure is not the pump failing, it's direct evidence you have unloaded the ventricle. The four timing errors get sorted by harm rather than by name, which is the distinction that shows understanding rather than recall. Early inflation and late deflation both load the ventricle during ejection and are the dangerous pair — late deflation worst of all, because the ventricle is ejecting against an inflated balloon. Late inflation and early deflation merely waste benefit, although early deflation can drive retrograde coronary and carotid flow and cause angina. Then triggers, the asynchronous mode and why you'd ever want it, and why arrhythmia is the balloon pump's great enemy. Indications and contraindications follow, including the most satisfying piece of physiology in the episode: why a balloon pump helps in acute severe mitral regurgitation. The ventricle has two exits, and how much blood goes each way depends on the relative resistance of the two routes — so dropping aortic end-diastolic pressure makes the forward path easier, the regurgitant fraction falls, and forward output rises. You're not fixing the valve, you're changing the arithmetic while somebody organises theatre. And on the other side, why aortic regurgitation is an absolute hard stop: everything the balloon does in diastole raises aortic root pressure, so in an incompetent valve you are augmenting the leak straight back into a failing ventricle. Then placement and the landmarks that matter, what TOE adds, the daily chest film, complications split into insertion, use and removal, and back to the 2am patient — falling urine output means think down, a lost left radial pulse means think up, and helium or blood in the tubing means rupture and it comes out now. We finish on the trap. IABP-SHOCK II was negative, and Altshock-2 in 2025 was stopped for futility in heart failure–related shock. So why is there one running in bed four? The answer isn't to ignore the evidence — it's to notice what those trials actually studied, which was routine, unselected use in two specific shock populations. That is a different question from the patient who cannot come off bypass, the one with acute severe mitral regurgitation waiting for theatre, or the one who needs to survive four hours until the cath lab. Chapters (00:00) Cold open — the augmented pressure has dropped (01:00) Why this episode, and what level we're pitching at (01:40) What it actually is, and why helium — two reasons (02:45) Counterpulsation: supply up and demand down at once (03:45) Inflation, and why the left ventricle is perfused in diastole (04:15) Deflation, afterload and wall stress (05:15) The trace — and why you put it on 1:2 (06:05) Reading a pair of beats (07:35) Lower is better: the comparison everyone misreads (08:05) The four timing errors, sorted by harm (10:35) Triggers, and the asynchronous mode (11:15) Arrhythmia and tachycardia (12:05) Indications (12:35) Acute mitral regurgitation, and post-infarct VSD (13:25) Contraindications — and why aortic regurgitation is absolute (15:15) Insertion, TOE, and the daily film (16:55) Complications: insertion, use, removal (18:35) Back to the 2am patient — migration up and down (19:55) Balloon rupture (20:15) Anticoagulation and weaning (21:15) IABP-SHOCK II, Altshock-2, and the trap (24:15) Wrap-up Key takeaways Helium for two reasons: low density so it shuttles fast, and high solubility so rupture is survivable The balloon occupies 80–90% of the aortic cross-section, inflating in diastole and deflating before systole It raises myocardial oxygen supply and lowers demand simultaneously — almost nothing else does Diastolic augmentation raises coronary perfusion pressure; presystolic deflation drops aortic end-diastolic pressure, and therefore afterload, wall stress and demand Read the trace on 1:2 so you have an unassisted control beat next to your assisted one Augmented diastolic should exceed unassisted systolic — the tallest thing on the screen should be the balloon, not the heart A lower assisted systolic pressure is good: it's evidence of unloading, not of pump failure Early inflation and late deflation load the ventricle during ejection and are the dangerous errors; late inflation and early deflation waste benefit, though early deflation can cause retrograde coronary flow and angina Arrhythmia is the balloon pump's great enemy; above a rate of about 120 you may get better support at 1:2 than 1:1 In acute severe mitral regurgitation, reducing aortic end-diastolic pressure shifts flow from the regurgitant route to the forward one Aortic regurgitation is an absolute contraindication because you would be augmenting the leak into an already failing ventricle — along with dissection, aneurysm, a prosthetic aorta, and futility Tip at the level of the carina and at least 2 cm below the aortic knob, just distal to the left subclavian, balloon above the diaphragm — checked every single day Falling urine output or a distended abdomen means think downward migration; a lost or damped left radial trace means think upward Helium or blood in the tubing means rupture: stop and remove urgently, before clot inside the balloon entraps it Wean by ratio or augmentation percentage, judged on haemodynamics, urine output and lactate rather than on the machine IABP-SHOCK II and Altshock-2 were negative for routine use in specific shock populations — which is not the question you are usually asking on a cardiac unit References / further reading Thiele H et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock (IABP-SHOCK II). N Engl J Med 2012; 367: 1287–96 Thiele H et al. Intra-aortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomised IABP-SHOCK II trial. Circulation 2019 Early intra-aortic balloon support for heart failure-related cardiogenic shock (Altshock-2): a randomised clinical trial. J Am Coll Cardiol 2025 Møller JE et al. Microaxial flow pump or standard care in infarct-related cardiogenic shock (DanGer Shock). N Engl J Med 2024 Thiele H et al. Extracorporeal life support in infarct-related cardiogenic shock (ECLS-SHOCK). N Engl J Med2023 Byrne RA et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023 Krishna M, Zacharowski K. Principles of intra-aortic balloon pump counterpulsation. Contin Educ Anaesth Crit Care Pain 2009 Follow the podcast Bluesky: @cardiacoutput.bsky.social X: @CardiacOutputMC If you've found this useful, a follow or a share genuinely helps other trainees find it — and do get in touch if there's a topic you'd like covered. This podcast is for medical education for healthcare professionals. It is not clinical advice. Weaning and anticoagulation practice described reflects local Wythenshawe practice at the time of recording — always follow your own centre's guidelines and current local policy.